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We identified a Dectin-2 N170I mutation in an immunocompromised patient who succumbed to 
invasive aspergillosis. This mutation results in an early stop codon, poor receptor expression and 





















Immunocompromised patients are highly susceptible to invasive aspergillosis. Herein, we identified a 
homozygous deletion mutation (507 del C) resulting in a frameshift (N170I) and early stop codon in 
the fungal binding Dectin-2 receptor, in an immunocompromised patient. The mutated form of 
Dectin-2 was weakly expressed, did not form clusters at/near the cell surface and was functionally 
defective. PBMCs from this patient were unable to mount a cytokine (TNF, IL-6) response to A. 
fumigatus and this first identified Dectin-2-deficient patient succumbed to invasive aspergillosis. 
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Invasive fungal infections including invasive aspergillosis (IA) represent a severe disease burden in 
immunocompromised patients such as acute myeloid leukemia and allogeneic hematopoietic stem 
cell transplant (HSCT) patients. Absence of a robust anti-fungal immune response permits fungal 
colonization, invasive growth and disease. IA mortality is unacceptably high, (30-80%) in allogeneic 
HSCT recipients [1, 2]. Therefore, patients are empirically treated with anti-fungal therapies.  
 
The C-type lectin-like receptors (CLRs) Dectin-1 and Dectin-2 drive anti-fungal immune responses 
against Candida and Aspergillus [3-7]. A Dectin-1 single nucleotide polymorphism (SNP) (Y238X) has 
been associated with mucocutaneous candidiasis [8] and increased susceptibility to IA [9]. SNPs in 
Dectin-2 have been associated with IA [10]; however, their functional consequences are unknown. 
Herein, we characterized a novel Dectin-2 exonic deletion mutation identified in an 
immunocompromised patient who succumbed to IA.  
METHODS 
Ethics Statement 
The study was approved by NISCHR Research Ethics Committee (reference: 14/WA/1119). Written 
informed consent was obtained from patients in the study. Animal work was performed according to 
institutional and UK Home Office guidelines. This study was performed in accordance with the 
Project License. Procedures were approved by Cardiff University Animal Welfare and Ethical Review 
Body and UK Home Office. The animal care and use protocol adhered to the Animals (Scientific 





















RNA was extracted from patient blood samples using PAXgene Blood RNA kit (Qiagen) and cDNA was 
generated using Reverse Transcription Kit (Thermofisher Scientific). Dectin-2 DNA was amplified and 
sequenced from patient cDNA by PCR using primers (Supplementary Table 1).  
 
Structural Analysis 
The structure of wild type (WT) Dectin-2, PDB accession code 5VYB, was used as the starting model. 
COOT was used to implement mutations and model readjustment. REFMAC5 (CCP4) was used to 
regularize model geometry.  
 
Cloning and Transfection 
WT and mutant CLEC6A/Dectin-2-pFB-NEO (Stratagene) and pHR’SIN-cPPT-SXW (pSXW) constructs, 
with an N-terminus FLAG-tagged Dectin-2, were generated using primers (Supplementary Table 1). 
FLAG-tagged Dectin-2 WT and mutant PCR products were inserted into pFB-NEO using In-Fusion 
Cloning kit (Clontech). Stellar Competent Cells (Clontech) were transformed with CLEC6A/Dectin-2-
FLAG-Tag constructs and grown in LB Broth (Sigma) before plasmid DNA was extracted using DNA 
Mini/Midiprep Kit (Thermofisher Scientific/Qiagen). FLAG-tagged Dectin-2 WT and mutant PCR 
products were inserted into SXW lentiviral vector using In-Fusion Cloning kit. Top10 competent E. 
coli (NEB) were transformed with CLEC6A/Dectin-2-FLAG-Tag constructs and grown in LB broth 
before plasmid DNA was extracted using DNA Miniprep Kit. HEK293T cells cultured in DMEM 
medium (with 10% Fetal bovine serum (FBS), 100U/ml penicillin/streptomycin (Thermofisher 



















WT or mutant Dectin-2, using Fugene-6 Transfection Reagent (Promega). 48 h later cells were 
harvested for RNA/protein analysis. 
 
Lentivirus infection 
HEK293T cells cultured in DMEM medium with 10% FBS and 100U/ml penicillin/streptomycin were 
co-transfected with 1.5µg pR8.91, 1µg pMD2G and either pSXW empty vector, Dectin-2 WT pSXW or 
Dectin-2 N107I pSXW, using Effectene Transfection Reagent (Qiagen). 48 h and 72 h later 
supernatant was collected, filtered using 0.45µm sterile millexGP filter (Millipore Ireland Ltd.) and 
overlaid on 20% sucrose (Sigma) gradient in ultracentrifuge conical tubes (Beckman Coulter). The 
gradient was centrifuged at 120,000 g at 4°C for 90 min and virus pellet re-suspended in AIM V 
medium (Thermofisher Scientific). Bone-marrow (BM) cells were isolated from Dectin-1-Dectin-2 
(D1D2) DKO mice. BM derived macrophages (BMDMs) were generated as previously described [7]. 
For lentiviral infection, BMDMs were harvested and lentivirus was added in the presence of fresh 
media containing M-CSF. 
 
Determination of Dectin-2 expression 
48 h after transfection of HEK293T cells and 72 h after infection of D1D2 DKO BMDMs, RNA was 
extracted using TRIZOL (Thermofisher Scientific) and purified using RNeasy Mini Kit (Qiagen). cDNA 
was synthesized using TaqMan Reverse Transcription Kit (Invitrogen). CLEC6A/Dectin-2 mRNA was 
quantified by qPCR using ABI Taqman Primer/Probe Sets (Thermofisher Scientific) and normalized 
against HPRT1. Dectin-2 protein expression was measured by intracellular FACS staining with anti-





















72 h after lentiviral infection, D1D2 DKO BMDMs were collected and centrifuged. The pellet was 
fixed with BD Cytofix/Cytoperm solution (BD Biosciences), washed with BD Perm-Wash solution (BD 
Biosciences) and blocked with FACS block solution (DPBS, 5mM EDTA, 2mM NaN3, 0.5% BSA, 5% 
Rabbit serum) containing 4μg/ml 2.4G2. Cells were stained with anti-CD11b (M1/70 Biolegend) and 
anti-FLAG (L5 Biolegend) and washed with BD Perm-Wash. 4’,6-diamidino-2-phenylindole (DAPI; 
Thermofisher Scientific) was added before cells were washed and resuspended in DPBS. 104 cells per 
sample were cytospun and mounted with Prolong Gold Antifade (Fisher Scientific). Cells were 
imaged using a Zeiss Cell Observer Spinning Disk confocal microscope with a 63x objective to obtain 
Z-stacks of the whole cell thickness. Images were then analyzed using Imaris 9.3.1 to obtain 3D 
reconstruction of cell structure. 
 
Fungal Cultures 
A. fumigatus 13073 (ATCC) was cultured on potato dextrose agar for 7 days at 37C. Conidia were 
harvested and passed through a 40M filter to remove hyphal fragments. Resting conidia were 
washed and resuspended in DPBS [7]. C. albicans SC5314 (ATCC) was cultured on YPD agar plates 
overnight at 30C, then cultured in YPD broth for 16 h at 30oC with shaking, washed with DPBS and 
resuspended in DPBS [5].   
Generation of Bone-Marrow Derived Dendritic Cells (BMDCs)  
BMDCs were generated by culturing BM cells for 8-10 days in RPMI 1640 medium containing 10% 
FBS, 2mM L-glutamine (Thermofisher Scientific), 100U/ml penicillin/streptomycin, 10mM HEPES (Life 
Technologies), 1% NEAA (Life Technologies), 1mM Sodium pyruvate (Thermofisher Scientific), 50μM 





















Human peripheral blood mononuclear cells (PBMCs) were isolated from patient blood using 
FicollPLUS (Sigma), washed with PBSMg+Ca+ (Thermofisher Scientific) and washed three times with 
RPMI 1640. Cells were resuspended in PBMC media (RPMI 1640 with 10% FBS, 2% human serum 
(Sigma), 10mM L-glutamine (Thermofisher Scientific), 10mM Sodium pyruvate and 100μg/ml 
Gentamicin (Thermofisher Scientific)). PBMCs were rested for 4 h before 100μl of 5x106 PBMCs/ml 
were challenged with 100μl of 1μg/ml LPS or 100μl of 5x106/ml A. fumigatus swollen conidia. 
Swollen conidia were cultured in RPMI at 37oC for 6 h. After 24 h supernatant was collected, and 
cytokines measured by ELISA (R&D). WT and Dectin-2 KO BMDCs were re uspended in RPMI 
containing 10% FBS and 100U/ml penicillin/streptomycin. 100μl of 1x106 BMDCs/ml were challenged 
with 100μl of 1x106/ml A. fumigatus conidia, 100μl of 1x106/ml C. albicans or 100μl of 2ng/ml LPS. 
Amphotericin B (2.5µg/ml) was added to C. albicans 2 h after stimulation. After 24 h supernatant 
was collected, and cytokines measured by ELISA (R&D). 
 
Statistical Methods 
Data were analyzed using GraphPad Prism. Data are presented as means ± SEM. One-way ANOVA 
followed by Tukey’s post-test or Two-way ANOVA followed by Bonferroni’s post-test was used for 
statistical analysis for multiple groups. When data were not normally distributed, it was transformed 
by Y=sqrt(Y+0.5) and ANOVA. p values less than 0.05 were considered statistically significant: 





















CLEC6A (Dectin-2) Mutation 
The patient possessed a homozygous base pair deletion (507delC) in exon 6 of Dectin-2 (CLEC6A) 
(Supplementary Figure 1A), which causes a frame shift (N170I) and premature termination of Dectin-
2 (Figure 1A). Loss of Cys176 removes a disulphide bridge, while loss of Asp191 removes a Ca2+ and 
Na+ stabilizing bridge (Figure 1B) and loss of the final -strand would leave a large hole at the core of 
the protein (Figure 1C), resulting in failure of the protein to fold. Furthermore, mutant Dectin-2 
could not bind its ligand (Supplementary Figure 1B-C). Therefore, this Dectin-2 mutation likely has 
serious functional and clinical consequences.  
 
Based on computational modelling, we hypothesized that mutant Dectin-2 would not produce a 
stable protein product. HEK293T cells expressing mutant Dectin-2 displayed increased RNA levels but 
minimal protein levels compared to WT Dectin-2 (Supplementary Figure 1D-F). Similarly, Dectin-1-
Dectin-2 DKO BMDMs expressing mutant Dectin-2 displayed normal RNA levels (Figure 1D) but 
minimal protein levels compared to BMDMs expressing WT Dectin-2 (Figure 1E-F). Furthermore, 
while WT Dectin-2 clustered at/near the cell surface, mutant Dectin-2 was expressed at low levels 
throughout the cytosol and did not form clusters (Figure 1G, Supplementary Figure 1G). Together, 
these data indicate that Dectin-2 N170I does not form a stable protein product, is minimally 
expressed and therefore functionally defective. 
Functional Consequences of CLEC6A Mutation 
To determine the functional consequences of Dectin-2 N170I, we tested whether the patients in our 
study were able to mount an effective immune response against A. fumigatus. Most WT PBMCs 
produced LPS- and A. fumigatus- induced cytokines. However, mutant Dectin-2 PBMCs only 



















role for Dectin-2 in A. fumigatus-induced cytokine production we utilized Dectin-2 KO cells. Dectin-2 
KO BMDCs displayed reduced A. fumigatus- (Figure 2B) and C. albicans-induced cytokine production 
compared to WT controls whilst they displayed normal LPS-induced cytokine production (Figure 2C). 
However, Dectin-2 did not contribute to fungal killing (Supplementary Figure 2A).  
 
We next investigated whether Dectin-2 mediated binding to A. fumigatus. Dectin-1-Dectin-2 DKO 
BMDMs expressing mutant Dectin-2 displayed a modest reduction in binding A. fumigatus compared 
to DKO BMDMs expressing WT Dectin-2 (Supplementary Figure 2B-C). A. fumigatus-induced trained 
immunity could be significantly reduced by blocking Dectin-2 in human monocytes (Supplementary 
Figure 2D). Together, these data indicate Dectin-2 N170I has detrimental consequences for anti-
fungal immunity. In agreement with this, the patient was diagnosed with probable IA and lung 
abnormalities consistent with fungal infection, which progressively worsened until death 
(Supplementary Table 2).  
DISCUSSION 
Herein, we characterized a novel Dectin-2 N170I mutation identified in a HSCT patient who 
succumbed to IA. This mutation results in truncation of Dectin-2 and radically alters the receptor’s 
tertiary structure, leading to significantly reduced expression. Dectin-2 is important for fungal 
binding, trained immunity, and fungal-induced cytokine production.  
 
Multiple polymorphisms in CLRs and their signaling component CARD9 increase susceptibility to 
fungal infection [9, 11], some even without immune suppression [8]. Two patients with reduced 
CARD9 protein expression developed IA [12] and HSCT patients with the Dectin-1 Y238X SNP, which 
results in a truncated CLR, displayed increased susceptibility to IA [9]. Here, we demonstrate the 



















recipient prior to SCT; however, up to 70% of tissue resident cells remain from host origin and may 
persist for up to one year [13-15]. The patient displayed signs of A. fumigatus infection <1-year post-
SCT, when host cells expressing mutant Dectin-2 were likely present in the lung. While the patient 
succumbed to IA, further patients would be required to confirm a direct link between Dectin-2 N170I 
and IA. 
 
Structural modelling of Dectin-2 N170I predicted incorrect folding of the protein. Consistent with 
this, we showed reduced expression of Dectin-2 N170I at the cell surface despite the presence of 
RNA and low level of dispersed intracellular protein. These results suggest Dectin-2 N170I forms an 
unstable structure, is poorly transported to the cell membrane and is minimally expressed, similar to 
Dectin-1 Y238X [8, 9]. Furthermore, Dectin-2 predominantly recognizes mannose, and hence 
Aspergillus, through its EPN motif, a structure lost in Dectin-2 N170I [4]. 
 
Dectin-2 generates robust cytokine and chemokine responses against A. fumigatus [4] and mice 
deficient in Dectin-2 are susceptible to C. albicans infection [5]. Here, we found a significant role for 
Dectin-2 mediating A. fumigatus- and C. albicans-induced TNF and IL-6 secretion. Similarly, PBMCs 
from CARD9-deficient patients display impaired fungal-induced cytokine production [16] and mice 
with TNF blockade or IL-6 deficiency are highly susceptible to IA [17, 18]. Dectin-2 has previously 
been shown to bind to A. fumigatus hyphae [4], and we observed a modest reduction in binding of 
mutant Dectin-2 to A. fumigatus compared to WT Dectin-2. Importantly, we observed Dectin-2 





















Our research is the first to functionally characterize a Dectin-2 mutation associated with decreased 
anti-fungal responses. Furthermore, the Dectin-2 mutant patient developed, and succumbed to IA. 
The Dectin-2 N170I mutation renders the CLR functionally null and loss of Dectin-2 results in 
defective anti-fungal responses. Identifying mutations that increase patient’s fungal susceptibility 
may permit a personalized approach and enable targeted prophylaxis of patients at high-risk of 




















CONFLICT OF INTEREST 
The authors have no conflict of interest.  
 
ACKNOWLEDGEMENTS 
SJO was funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal 
Society (Grant Number 099953/Z/12/Z) and by the T. Maelgwyn Davies Bequest fund. PRT is 
supported by a Wellcome Trust Investigator Award (107964/Z/15/Z) and the UK Dementia Research 
Institute. ES was supported by an MRC GW4 BioMed DTP PhD studentship. MAC is supported by 
BBSRC Discovery Fellowship (BB/T009543/1). 
 
CORRESPONDENCE 
Selinda J. Orr  
Wellcome-Wolfson Institute for Experimental Medicine 
School of Medicine, Dentistry and Biomedical Sciences 
Queen's University Belfast 
Email: S.Orr@qub.ac.uk 




















Figure 1: Dectin-2 mutation results in minimal protein expression. (A) Partial amino acid sequence 
of wild-type (WT) and mutant (507delC) Dectin-2 with key residues and EPN mannan-binding motif 
highlighted. (B) The fold of WT Dectin-2 5VYB (cartoon) in complex with mannan (stick model). Blue 
= present in the mutant protein, orange = absent in the mutant protein. Two Ca2+ atoms (green 
spheres) and a Na+ atom (purple) are also displayed. (C) Predicted surface model of Dectin-2 
covering the mutant structural elements only. The final β-strand at the core of the structure is 
missing in the mutant, resulting in a collapse of the motif, corruption of ligand interface and inability 
to bind mannan. (D-G) BMDMs from Dectin-1-Dectin-2 DKO mice were infected with constructs 
expressing FLAG-tagged Dectin-2 WT, mutant or empty vector and harvested 72 h later. (D) RNA was 
isolated, cDNA was prepared, and CLEC6A mRNA transcript was detected by RTqPCR. mRNA levels 
were normalized to HPRT1. Graph displays mean +/- SEM from 3 independent experiments. One-
way ANOVA with Tukey’s post-test on transformed data. (E-F) Cells were permeabilized, stained with 
anti-FLAG and analyzed by flow cytometry. (E) Dashed black line = empty vector, solid black line = 
Dectin-2, solid grey line = Dectin-2 mutant. Histogram representative of 3 independent experiments. 
(F) Graph displays mean +/- SEM mean fluorescent intensity (MFI) from 3 independent experiments. 
One-way ANOVA with Tukey’s post-test. (G) BMDMs were stained with anti-CD11b (magenta) and 






















Figure 2: Dectin-2 mediates cytokine response to A. fumigatus and C. albicans. (A) Patient PBMCs 
were stimulated with A. fumigatus swollen conidia at a ratio of 1:1 or with LPS for 24 h. Cytokine 
levels in supernatants were measured by ELISA. Graphs show mean +/- SEM from 41 patients with 
WT Dectin-2 and 1 patient homozygous for mutant Dectin-2. Patient results are additionally 
stratified by their IA status. (B) BMDCs from WT and Dectin-2 KO mice were stimulated with A. 
fumigatus conidia at a ratio of 1:1 for 24 h. Cytokine levels in supernatants were measured by ELISA. 
Graphs show mean +/- SEM from 4 independent experiments, 2-way ANOVA on transformed data 
with Bonferroni’s post-test. (C) BMDCs from WT and Dectin-2 KO mice were stimulated with C. 
albicans at a ratio of 1:1 or LPS for 24 h. Amphotericin B was added after 2 h and supernatants were 
harvested after 24 h. Graphs show mean +/- SEM from 3 independent experiments, 2-way ANOVA 
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